https://www.bostonscientific.com/Agent/dcb
赞助Provides a targeted and therapeutic drug to the coronary lesion in ISR patients. Designed to maximize drug transfer with reliable and efficient drug-coated technology.
网站访客: 过去一个月超过 10K 名
Reduces Dwell Time · Cutting-Edge Technology · Compliance-Driven · Clinical Validation